B E Storer

An evaluation of phase I clinical trial designs in the continuous dose–response setting

B E Storer, B. Storer, 2001, Statistics in medicine.

Assessing breast self-examination.

B E Storer, R R Love, P A Newcomb, 1995, Preventive medicine.

Design and analysis of phase I clinical trials.

B E Storer, B. Storer, 1989, Biometrics.

Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.

B E Storer, B. Storer, R. Brown, 1989, Cancer research.

General relative risk functions for case-control studies.

N E Breslow, B E Storer, N. Breslow, 1985, American journal of epidemiology.

Screening sigmoidoscopy and colorectal cancer mortality.

B E Storer, P. Newcomb, P. Marcus, 1992, Journal of the National Cancer Institute.

Small-sample confidence sets for the MTD in a phase I clinical trial.

B E Storer, Barry E. Storer, 1993, Biometrics.

Risk factors for carcinoma in situ of the breast.

P L Remington, B E Storer, P. Remington, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.